| Literature DB >> 26299347 |
John T Brogan1, Sydney L Stoops1, Suzanne Brady2, Hanbing An3, Connie Weaver3, J Scott Daniels4, R Daniel Beauchamp5, Craig W Lindsley6, Alex G Waterson7.
Abstract
E-cadherin is a ubiquitous trans-membrane protein that has important functions in cellular contacts and has been shown to play a role in the epithelial mesenchymal transition. We have previously reported the use of an HTS screen to identify compounds that are capable of restoring e-cadherin in cancer cells. Here, we report the additional medicinal chemistry optimization of these molecules, resulting in new molecules that restore e-cadherin expression at low micromolar concentrations. Further, we report preliminary pharmacokinetic data on a compound, ML327, that can be used as a probe of e-cadherin restoration.Entities:
Keywords: Cancer; E-cadherin; Epithelial mesenchymal transition; Structure activity relationship
Mesh:
Substances:
Year: 2015 PMID: 26299347 PMCID: PMC4567403 DOI: 10.1016/j.bmcl.2015.07.104
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823